Efectos adversos relacionados al uso de AINEs en el manejo de osteoartritis felina y canina

dc.creatorGonzález-Corrales, Daniela
dc.creatorMonge-Quirós, Tatiana
dc.creatorAlfaro-Mora, Ramses
dc.date.accessioned2020-11-11 00:00:00
dc.date.accessioned2022-07-01T17:16:17Z
dc.date.accessioned2022-09-29T12:21:46Z
dc.date.available2020-11-11 00:00:00
dc.date.available2022-07-01T17:16:17Z
dc.date.available2022-09-29T12:21:46Z
dc.date.created2020-11-11 00:00:00
dc.date.created2022-07-01T17:16:17Z
dc.date.issued2020-11-11
dc.identifierhttps://repositorio.unisucre.edu.co/handle/001/1627
dc.identifier10.24188/recia.v13.n1.2021.781
dc.identifier2027-4297
dc.identifierhttps://doi.org/10.24188/recia.v13.n1.2021.781
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3749863
dc.languagespa
dc.publisherUniversidad de Sucre
dc.relationBatlouni M. Antiinflamatorios No Esteoides: Efectos Cardiovasculares, Cerebrovasculares y Renales. Arq Bras Cardiol. 2010; 94(4):556-563. http://dx.doi.org/10.1590/S0066-782X2010000400019
dc.relationKhan S, McLean M. Toxicology of Frequently Encountered Nonsteroidal Anti-Inflammatory Drugs in Dogs and Cats. Vet Clin Small Anim. 2012; 42:289–306. http://dx.doi.org/10.1016/j.cvsm.2012.01.003
dc.relationIff I. Non-steroidal anti-inflamatory drugs in dogs and cats-what´s new? Vet Irelan J. 2011; 1(9):506-510. https://search.ebscohost.com/login.aspx?direct=true&db=asn&AN=86200534&lang=es&site=ehost-live
dc.relationBurian M, Geisslinger G. COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol Ther. 2005; 107(2):139–154. http://dx.doi.org/10.1016/j.pharmthera.2005.02.004
dc.relationLópez-Beceiro L, Fernández-Pérez S, Benguria-Astorqui L. Perforación gastrointestinal como consecuencia del uso de AINEs, Rev Complut Cienc Vet. 2007; 1(2):633-640. https://revistas.ucm.es/index.php/RCCV/article/view/RCCV0707230633A/22763
dc.relationAlfaro R, Granados M, Camacho D. Polifarmacia en especies menores de clínicas veterinarias de la provincia de Heredia, en Costa Rica. Rev Colomb Cienc Quím. Farm. 2018; 47(1):5-13. https://doi.org/10.15446/rcciquifa.v47n1.70652
dc.relationMüntener C, Bruckner L, Kupper J, Althaus F, Schäublin M. Vigilance for veterinary medicinal products: reports of adverse reactions in the year 2012. Schweiz Arch Tierheilkd. 2013; 155(11):613-620. http://dx.doi.org/10.1024/0036-7281/a000523
dc.relationMüntener C., Bruckner L, Kupper J, Althaus F, Schäublin M. Vigilance for veterinary medicinal products: reports of adverse reactions in the year 2013. Schweiz Arch Tierheilkd. 2014; 156(11):519-525. http://dx.doi.org/10.1024/0036-7281/a000642
dc.relationRadi Z. Pathophysiology of cyclooxygenase inhibition in animal models, Toxicol Pathol. 2009; 37:34-46. https://doi.org/10.1177/0192623308329474
dc.relationBergh M, Budsberg S. The coxib NSAIDs: potential clinical and pharmacologic importance in veterinary medicine. J Vet Intern Med. 2005; 19:633-643. https://doi.org/10.1892/0891-6640(2005)19[633:tcnpca]2.0.co;2
dc.relationStolfi C, De Simone V, Pallone F, Monteleone G. Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer. Int J Mol Sci. 2013; 14:17972-17985. http://dx.doi.org/10.3390/ijms140917972
dc.relationRao P, Kabir S, Mohamed T. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development. Pharmaceuticals. 2010; 3:1530-1549. http://dx.doi.org/10.3390/ph3051530
dc.relationSchellack N, Schellack G, Fourie J. A review of nonsteroidal anti-inflammatory drugs. S Afr Pharm J. 2015; 82(3):8-18. http://www.sapj.co.za/index.php/SAPJ/article/download/1988/3481
dc.relationMaddison J. Cats and NSAIDs- what are the issues?. Irish Veterinary Journal. 2007; 60(3):174-178. https://search.ebscohost.com/login.aspx?direct=true&db=asn&AN=24946789&lang=es&site=ehost-live
dc.relationSchwab J, Schluesener H, Laufer S. COX-3: just another COX or the solitary elusive target of paracetamol? Lancet. 2003; 361(9362): 981-982. https://doi.org/10.1016/S0140-6736(03)12841-3
dc.relationChandrasekharan N, Dai H, Turepu K, Evanson N, Tomsik J, Elton T. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. PNAS. 2002; 99(21):13926-13931. http://dx.doi.org/10.1073/pnas.162468699
dc.relationSparkes A, Heiene R, Lascelles B, Malik R, Sampietro L, Robertson S. ISFM and AAFP consensus guidelines: long – term use of NSAIDs in cats. J Feline Med Surg. 2010; 12(7):521-538. https://www.wsava.org/wp-content/uploads/2020/01/Guidelines-for-the-Long-Term-Use-of-NSAIDS-in-Cats.pdf
dc.relationJones R. Nonsteroidal anti-inflammatory drugs in the cat. Vet Anaesth Analg. 2007; 34:225–227. http://dx.doi.org/10.1111/j.1467-2995.2007.00372.x
dc.relationTangmahakul N., Soontornvipart K., Nganvongpanit K. Comparison of the efficacy of firocoxib and carprofen in clinical use for canine coxofemoral osteoarthritis. Thai J Vet Med. 2015; 45(3):351-362. http://www.thaiscience.info/Journals/Article/TJVM/10978194.pdf
dc.relationLess P. Pharmacology of drugs used to treat osteoarthritis in veterinary practice. Inflammopharmacology. 2003; 11(4):385-399. https://link.springer.com/article/10.1163/156856003322699564
dc.relationInnes J, Clayton J, Lascelles B. Review of the safety and efficacy of long-term NSAID use in the treatment of canine osteoarthritis. Vet Rec. 2010; 166:226-230. http://dx.doi.org/10.1136/vr.c97
dc.relationInnes J, O´Neill T, Lascelles D. Use of non-steroidal anti-inflammatory drugs for the treatment of canine osteoarthritis. In Practice. 2010; 32:126-137. http://dx.doi.org/10.1136/inp.c1436
dc.relationLomas A, Grauer G. The Renal Effects of NSAIDs in Dogs. J Am Anim Hosp Assoc. 2015; 51(3):197-203. https://doi.org/10.5326/JAAHA-MS-6239
dc.relationSanderson R, Beata C, Flipo R, Genevois J, Macias C, Tacke S. Systematic review of the management of canine osteoarthritis. Vet Rec. 2009; 164(14):418-424. https://doi.org/10.1136/vr.164.14.418
dc.relationLees P., Pelligand L, Elliott J, Toutain P, Michels G, Stegemann M. Pharmacokinetics, pharmacodynamics, toxicology and therapeutics of mavacoxib in the dog: a review. J Vet Pharmacol Ther. 2014; 38(1):1-14. http://dx.doi.org/10.1111/jvp.12185
dc.relationRobertson S. Osteoarthitis in cats: what we now know about recognition and treatment. Vet Med. 2008; 103(11):611-616. https://search.ebscohost.com/login.aspx?direct=true&db=asn&AN=35372473&lang=es&site=ehost-live
dc.relationRuiz J. Factores fisiológicos que modifican la acción de los fármacos en medicina veterinaria. Rev Col Cienc Pec. 2001; 14(1):36-48. https://revistas.udea.edu.co/index.php/rccp/article/view/323750/20780937
dc.relationLascelles B, Henderson AJ, Hackett IJ. Evaluation of the clinical efficacy of meloxicam in cats with painful locomotor disorders. J Small Anim Pract. 2001; 42(12):587-593. https://doi.org/10.1111/j.1748-5827.2001.tb06034.x
dc.relationHunt J, Dean R, Davis G., Murrell J. An analysis of the relative frequencies of reported adverse events associated with NSAID administration in dogs and cats in the United Kingdom. Vet J. 2015; 206(2):183–190. https://doi.org/10.1016/j.tvjl.2015.07.025
dc.relationLascelles B, Hansen B, Roe S, DePuy V, Thomson A, Pierce C. Evaluation of client– specific outcome measures and activity monitoring to measure pain relief in cats with osteoarthritis. J Vet Intern Med. 2007; 21(3):410-416. https://doi.org/10.1111/j.1939-1676.2007.tb02983.x
dc.relationSzweda M, Szarek J, Kielbowicz Z, Szynaka B. Side-effects of non-steroidal anti-inflammatory drugs on the liver in dogs and hepatoprotective effect of plant remedies. Bull Vet Inst Pulawy. 2014; 58(3):459-466. https://doi.org/10.2478/bvip-2014-0070
dc.relationValadan M, Shojaee-Tabrizi A, Sarchahi AA, Derakhshandeh A, Mirzaeian S. Comparison of gastric adverse effects of aspirin and celecoxib before and after eradicating Helicobacter spp. infection in dogs. IJVR. 2014; 15(2):154-158. http://ijvr.shirazu.ac.ir/article_2363_0eaf6030011d0bd11615ed312df0ebca.pdf
dc.relationKing J, Rudaz C, Borer L, Jung M, Seewald W., Lees P. In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study. Res Vet Sci. 2010; 88(3):497-506. https://doi.org/10.1016/j.rvsc.2009.11.002
dc.relationWebb C, Twedt D. Canine gastritis. Vet Clin North Am Small Anim Pract. 2003; 33(5):969-985. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124327/
dc.relationRichardson J. Management of Acetaminophen and Ibuprofen toxicosis in dogs and cats. J Vet Emerg Critic Care. 2007; 10(4):285-291. https://doi.org/10.1111/j.1476-4431.2000.tb00013.x
dc.relationDavis M, Williamson K. Gastritis and gastric ulcers in work dogs. Front Vet Sci. 2016; 3:30. https://doi.org/10.3389/fvets.2016.00030
dc.relationFusellier M, Desfontis J, Madec S. Effect of tepoxalin on renal function in healthy dogs receiving an angiotensin-converting enzyme inhibitor J Vet Pharmacol Ther. 2005; 28(6):581-586. https://doi.org/10.1111/j.1365-2885.2005.00685.x
dc.relationSurdyk K, Sloan D, Brown S. Evaluation of the renal effects of ibuprofen and carprofen in euvolemic and volume-depleted dogs. Intern J Appl Res Vet Med. 2011; 9:129-136. http://www.jarvm.com/articles/Vol9Iss2/Vol9%20Iss1Brown.pdf
dc.relationBoelsterli U. Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity. Toxicol Appl Pharmacol. 2003; 192(3):307-322. https://doi.org/10.1016/S0041-008X(03)00368-5
dc.relationReymond N, Speranza C, Gruet P, Seewald W, King J. Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial. J Vet Pharmacol Ther. 2012; 35(2):175-183. https://doi.org/10.1111/j.1365-2885.2011.01297.x
dc.relationNakagawa K, Yamagami T, Takemura N. Hepatocellular toxicosis associated with the alternate administration of carprofen and meloxicam in a siberian husky. J Vet Med Sci. 2005; 67(10):1051-1053. https://doi.org/10.1292/jvms.67.1051
dc.relationSiroka Z. The toxicity and adverse effects of selected drugs in animals – overview. Pol J Vet Sci. 2013; 16(1):181–191. http://journals.pan.pl/dlibra/publication/114082/edition/99140/content
dc.relationSutalo S, Ruetten M, Hartnack S. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats. J Vet Intern Med. 2015; 29(3):840-846. https://doi.org/10.1111/jvim.12580
dc.relationParkinson S, Tolbert K, Messenger K, Odunayo A, Brand M, Davidson G, el al. Evaluation of the Effect of Orally Administered Acid Suppressants on Intragastric pH in Cats. J Vet Intern Med. 2015; 29(1):104–112. https://doi.org/10.1111/jvim.12493
dc.relationTakeuchi H. The role of food for the formation and prevention of gastrointestinal lesions induced by aspirin in cats. Digestive Diseases and Sciences. 2013; 58(10):2840–2849. http://dx.doi.org/10.1007/s10620-013-2725-7
dc.relationSumano-López H, Ocampo-Camberos L. Farmacología Veterinaria 3 ed. McGraw-Hill Interamericana: México D.F; 2006. https://es.scribd.com/doc/55938774/Farmacologia-Veterinaria-Tercera-Edicion-Sumano-Ocampo
dc.relationPlumb D. Plumb´s Veterinary Drug Handbook. 7th ed, PharmaVet Inc: Wisconsin; 2011. https://books-library.online/files/download-pdf-ebooks.org-kupd-190.pdf
dc.relationEttinger S, Feldman E. Veterinary Internal Medicine. Diseases of the dog and the cat. 8th ed, Saunders Elsevier; 2017. https://evolve.elsevier.com/cs/product/9780323312110?role=student
dc.relationhttps://revistas.unisucre.edu.co/index.php/recia/article/download/e781/915
dc.relationNúm. 1 , Año 2021 : RECIA 13(1):ENERO-JUNIO 2021
dc.relatione781
dc.relation1
dc.relatione781
dc.relation13
dc.relationRevista Colombiana de Ciencia Animal - RECIA
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.rightsRevista Colombiana de Ciencia Animal - RECIA - 2020
dc.sourcehttps://revistas.unisucre.edu.co/index.php/recia/article/view/e781
dc.subjectSecondary effect
dc.subjectosteoarthritis
dc.subjectdrug therapy
dc.subjectrenal insufficiency
dc.subjectpets
dc.subjectcyclooxygenase inhibitors
dc.subjectEfectos secundario
dc.subjectosteoartritis
dc.subjecttratamiento farmacológico
dc.subjectinsuficiencia renal
dc.subjectmascotas
dc.subjectinhibidores de la ciclooxigenasa
dc.titleEfectos adversos relacionados al uso de AINEs en el manejo de osteoartritis felina y canina
dc.typeArtículo de revista
dc.typeJournal article


Este ítem pertenece a la siguiente institución